# Vera Therapeutics, Inc.: Form 8-K, filed May 17, 2024

- Company: [Vera Therapeutics, Inc.](/companies/vera.md) (CIK 1831828)
- Form: 8-K
- Filed: 2024-05-17
- Accepted by EDGAR: May 17, 2024, 17:15 ET
- Period: 2024-05-15
- Accession: 0000950170-24-061872
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1831828/000095017024061872/vera-20240515.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1831828/000095017024061872/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1831828/000095017024061872/vera-20240515.htm

Filed May 17, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-061872. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.